Millipore Sigma Vibrant Logo

MABN1863 Anti-SET-alpha, clone 5F4D9

Anti-Set-alpha, clone 5F4D9 is an antibody against Set-alpha for use in Western Blotting.

Anti-SET-alpha, clone 5F4D9 : SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.
Research Category: Neuroscience Research Sub-Category: Signaling Neuroscience Gene Symbol: SET UniProt Number: Q01105-1
View Products on Sigmaaldrich.com
MABN1863
100 μg  
Preis wird abgerufen...
Preis nicht abrufbar
Die Mindestmenge muss ein Vielfaches sein von
Maximum Quantity is
Bei Bestätigung Weitere Informationen
Sie haben () gespart
 
—
Bitte erfragen
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      Sonderaktionen

       

      Kontakt zum Kundenservice

      Übersicht

      Replacement Information

      Sonderaktionen

      100% Performance Guaranteed

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HWBMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABN1863
      DescriptionAnti-SET-alpha, clone 5F4D9
      Alternate Names
      • Protein SET-alpha
      • HLA-DR-associated protein II alpha
      • IGAAD, alpha isoform
      • Inhibitor of granzyme A-activated Dnase, alpha isoform
      • PHAPII, alpha isoform
      • I-2PP2A, alpha isoform
      • Phosphatase 2A inhibitor I2PP2A, alpha isoform
      • TAF-I alpha
      • Template-activating factor I, alpha isoform
      Background InformationProtein SET (UniProt Q01105; also known as HLA-DR-associated protein II, IGAAD, Inhibitor of granzyme A-activated DNase, PHAPII, I-2PP2A, Phosphatase 2A inhibitor I2PP2A, TAF-I, Template-activating factor I) is encoded by the SET gene (Gene ID 6418) in human. Protein SET (patient “SE translocation”) adopted its name when it was originally identified ia leukemia study in 1992. SET interacts with signaling pathways that promote normal cell growth and proliferation, as well as tumorigenesis and metastasis. SET protein inhibits PP2A by enhancing lyase activity of P450c17, a substrate for PP2A when it is Ser- and Thr-phosphorylated. Alternative splicings result in multiple SET isoforms, including SET-alpha (TAF-I alpha) and SET-beta (TAF-I beta), where the N-terminal 37-amino acid sequence in Set-α is replaced with a different sequence of a shorter length in Set-β. Both Set-α and Set-β are predominantly localized in the nucleus, but differ in their expression levels among various cell and tissue types. Set-β is predominant in the brain relative to Set-α, whereas the opposite pattern was observed in tissues such as the spleen.
      References
      Product Information
      FormatPurified
      PresentationPurified mouse monoclonal IgG1κ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-Set-alpha, clone 5F4D9 is an antibody against Set-alpha for use in Western Blotting.
      Key Applications
      • Western Blotting
      Application NotesWestern Blotting Analysis: 0.5 µg/mL from a representative lot detected SET-alpha in 10 µg of PC3 human prostate cancer cell lysate.
      Western Blotting Analysis: 2.0 µg/mL from a representative lot specifically detected SET-alpha, but not SET-beta in Ramos human Burkitt's lymphoma cell lysate (Courtesy of M. P. Vitek, Ph.D. Dr. Vitek is an employee and stockholder in Oncotide Pharmaceuticals, Inc. and a faculty member of Duke University Medical Center. Matters of potential personal and institutional conflict of interest are managed by the Duke University Medical Center Conflict of Interest Committee).
      Biological Information
      ImmunogenKLH-conjugated linear peptide corresponding to a sequence near the N-terminus of human SET-alpha.
      EpitopeNear N-terminus.
      Clone5F4D9
      ConcentrationPlease refer to lot specific datasheet.
      HostMouse
      SpecificityClone 5F4D9 recognizes an epitope sequence specific to spliced isoform SET-alpha (TAF-I alpha) of human protein SET (UniProt Q01105-1). The epitope sequence is not present in SET-beta (TAF-I beta) or any other human protein SET spliced isoforms reported by UniProt.
      IsotypeIgG1
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • SET
      Purification MethodProtein G purified.
      UniProt Number
      Molecular Weight~38 kDa observed. Band size appears larger than the calculated molecular weight of 33.36 kDa (Met1 removed) due to posttranslational modification (acetylation and/or phosphorylation).
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blotting in DU145 cell lysate.

      Western Blotting Analysis: 0.5 µg/mL of this antibody detected SET-alpha in 10 µg of DU145 human prostate cancer cell lysate.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      MABN1863 04055977350968